$2.55
▼ -2.7% Today
as of Oct 22, 16:46 ET
Last 30 days
Recent Press Releases & News
Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform
Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings
Artelo Biosciences Announces ART27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity
ARTL earnings at a glance
Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±2.1% on average; after the most recent report on May 14, 2026 it moved +1.3%. The share price of $2.55 sits near its 52-week low.
Overview
52-week range
$2.53
$179
0% of range
Avg surprise (last 0)
—
Avg reaction (last 2)
+2.1%
100% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.89 | — | — | — | — | financials |
| Thu May 14, 2026 | Mar/2026 | $4.00 | — | — | +655.6% | +1.3% | earnings |
| Wed Nov 12, 2025 | Sep/2025 | $-3.97 | — | — | — | — | earnings |
| Wed Aug 13, 2025 | Jun/2025 | $-5.61 | — | — | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.72 | — | — | — | +3.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-2.10 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-4.52 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.83 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-3M | $-3M | — | $-3M | $-3M | $-2M | — | $-1M |
| Net income | $-2M | $-3M | — | $-3M | $-3M | $-2M | — | $-1M |
| EPS (diluted) | $-0.89 | $-4.00 | — | $-3.97 | $-16.86 | $-12.55 | — | $-2.10 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | $4M | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $4M | $10M | $695,000 | $2M | $2M | — | $3M | $5M |
| Total assets | $6M | $13M | $3M | $4M | $4M | — | $5M | $7M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $1M | $6M | $4M | $5M | $6M | — | $2M | $775,000 |
| Total equity | $5M | $7M | $-1M | $-633,000 | $-1M | $652,000 | $3M | $6M |
Implied volatility — last 90 days
No IV snapshots yet for ARTL.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
ARTL earnings FAQ
How does ARTL stock usually react to earnings?
Across the last 2 reports the average next-day move was ±2.1%, up 2 times and down 0 times.